Exelon sNDA For Parkinson’s-Related Dementia Requires Just One Trial, Committee Says

FDA’s Peripheral & Central Nervous Systems Drugs Advisory Committee agrees that dementia associated with Parkinson’s disease qualifies as distinct from Alzheimer’s-type dementia.